Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Chinese Patent Office

Generated: November 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016131

« Back to Dashboard

NDA 016131 describes CLOMID, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. Additional details are available on the CLOMID profile page.

The generic ingredient in CLOMID is clomiphene citrate. There are sixteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.
Summary for 016131
Applicant:Sanofi Aventis Us
Ingredient:clomiphene citrate
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 016131
Suppliers and Packaging for NDA: 016131
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOMID clomiphene citrate TABLET;ORAL 016131 NDA AUTHORIZED GENERIC A-S Medication Solutions 50090-0677 50090-0677-1 30 TABLET in 1 CARTON (50090-0677-1)

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Farmers Insurance
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.